Nuvation Bio Inc. (NUVB-WT)

USD 0.16

(0.65%)

Total Debt Summary of Nuvation Bio Inc.

  • Nuvation Bio Inc.'s latest annual total debt in 2023 was 4 Million USD , down -5.94% from previous year.
  • Nuvation Bio Inc.'s latest quarterly total debt in 2024 Q2 was 289.62 Million USD , up 8099.89% from previous quarter.
  • Nuvation Bio Inc. reported annual total debt of 4.26 Million USD in 2022, up 39.44% from previous year.
  • Nuvation Bio Inc. reported annual total debt of 3.05 Million USD in 2021, down 0.0% from previous year.
  • Nuvation Bio Inc. reported quarterly total debt of 3.53 Million USD for 2024 Q1, down -11.85% from previous quarter.
  • Nuvation Bio Inc. reported quarterly total debt of 4 Million USD for 2023 Q4, down -10.24% from previous quarter.

Annual Total Debt Chart of Nuvation Bio Inc. (2023 - 2018)

Historical Annual Total Debt of Nuvation Bio Inc. (2023 - 2018)

Year Total Debt Total Debt Growth
2023 4 Million USD -5.94%
2022 4.26 Million USD 39.44%
2021 3.05 Million USD 0.0%
2020 - USD 0.0%
2019 - USD -100.0%
2018 600 Thousand USD 0.0%

Peer Total Debt Comparison of Nuvation Bio Inc.

Name Total Debt Total Debt Difference
ADC Therapeutics SA 124.37 Million USD 96.778%
Alto Neuroscience, Inc. 151.46 Million USD 97.354%
Annovis Bio, Inc. - USD -Infinity%
Biohaven Pharmaceutical Holding Company Ltd. 30.87 Million USD 87.023%
Ginkgo Bioworks Holdings, Inc. 241.76 Million USD 98.343%
Nuvation Bio Inc. 4 Million USD 0.0%
Arcus Biosciences, Inc. 11 Million USD 63.573%
Theriva Biologics, Inc. 2.15 Million USD -86.026%
Zymeworks Inc. 26.72 Million USD 85.005%